| News | |
|
PRESS RELEASES PIIPA is pleased to announce new leadership. Dr. Steven C. Price has joined PIIPA as CEO/President, from his previous appointment at the University of Wisconsin, Madison, where he was Director of University-Industry Relations. Press Release (Word Document) ------------------------ PIIPA commissioned a pro bono legal report from the IP clinic at American University's Washington College of Law, based on an issue framed together with the Peruvian Working Group. The report concludes that it is consistent with international treaties if a national patent law requires patent applicants to file proof that biological materials were obtained with a suitable access and benefit sharing agreement. The report has been delivered to INDECOPI and is being made available to the public to assist other developing countries in bilateral and multilateral trade negotiations. Press Release (Word Document) |
|
NEWS ARTICLES AND EVENTS Nature Biotechnology Vol. 22 No. 11 November, 2004 (PDF) Industry Wary of NIH Consultancy Moratorium ------------------------ Innovation Matters October, 2004 (Microsoft Word) PIIPA: Offering Free Legal Assistance to Developing Countries and Public Interest Non-Profits ------------------------ Intellectual Property Rights and Sustainable Development Portal www.iprsonline.org This portal contains a selection of relevant online documents and resources related to IPRs and sustainable development including a guide to IPRs, proposals submitted to the WTO, discussion papers classified by topics, a calendar of IPRs related events, latest news on IPRs, and links to listservs and relevant institutions working on IPRs. ------------------------ Bioprospecting Resource Manual (PDF) or (Microsoft Word) This Web Resource is intended to guide the on-line reader through the vast field of literature on the subject of bioprospecting. While this outline only represents a fraction of what is on-line, the resources listed below represent a balanced view of the subject matter, while taking into account the diverse viewpoints and debate on the subject of bioprospecting itself. Additional links are also provided for further reference and critical evaluation of the current activities and debates on this multi-faceted, ever-evolving and highly relevant topic in today’s global forum. ------------------------ Jan 12-2004 DC Team Gets to the Root of the Problem Article - Pro bono lawyers challenge N.J. company's patents involving tubers used for centuries by indigenous Peruvians. - LegalTimes ------------------------ Feb 12-16, 2004 AAAS Annual Meeting Powerpoint presentations from the SIPPI symposia in Seattle are now available online. To access the powerpoints, please view the SIPPI website at http://sippi.aaas.org. SIPPI hosted the following symposia at the Annual Meeting this year: --Intellectual Property Resources for International Development in Agriculture and Health --Intellectual Property and the Research Exemption: Its Impact on Science --An Open Forum: Intellectual Property Issues and the Contemporary Scientist ------------------------ March 16, 2004 WWF Center for Conservation Innovation Bioprospecting as a conservation tool: Experience from Panama Bioprospecting has been criticized as an ineffective tool for conservation and development because benefits in the form of royalties are highly uncertain (only a small fraction of plant extracts are developed into drugs) and take years to go into effect. However, the experience of the Panama International Cooperative Biodiversity Groups (ICBG) project suggests that, by conducting value-added bioprospecting research in biodiversity-rich nations with local scientists, benefits can be realized even if a drug never makes it to market. Billions of dollars are spent annually by pharmaceutical companies and governments to support drug discovery research at small biotech companies and universities. Dr. Kursar and Dr. Coley will discuss the experiences of the Panama ICBG project in conducting more of this research in the source country, creating a range of more immediate local benefits. They will also discuss the applicability of this model to efforts in other countries to link development with fully sustainable uses of biodiversity. Thomas A. Kursar is an Associate Professor in the Department of Biology, University of Utah and a Research Affiliate of the Smithsonian Tropical Research Institute in Panama City, Panama. Phyllis D. Coley is a Professor in the Department of Biology, University of Utah, and a Research Affiliate of the Smithsonian Tropical Research Institute, Panama City, Panama. They have worked actively on bioprospecting issues in Panama since 1991, and are currently leaders of the collections program of the Panama ICBG. Thomas A. Kursar, Associate Professor; Dept. of Biology, Univ. of Utah 257 South 1400 East; Salt Lake City, Utah 84112-0840; 801-581-8369 (FAX: 801-581-4668) Research Affiliate; Smithsonian Tropical Research Institute; Panama City, Panama |
|
Sector Related News AGREEMENTS
Michael A. Gollin. -Biological Materials Transfer Agreements,
Neither a borrower, nor a lender; For loan oft loses both itself and
friend, And borrowing dulls the edge of husbandry.” 13 Biotechnology. 243 – 244. 13 March (1995).
AGRICULTURAL TECHNOLOGY
Christine Suh. Biotech tackles hunger in Africa. UPI Science News
From the Science & Technology Desk. Published 3/12/2003
http://web.uct.ac.za/mailarchives/pesticides-l.archives/msg00258.html
Michael A. Gollin. At
the Crossroads: Intellectual
Property Rights and Agricultural Biotechnology, at 1, Third
Asia-Pacific Conference on Agricultural Biotechnology: Issues
and Choices, Thailand, 1996 (paper on file with author). Neil D. Hamilton. Who Owns Dinner: Evolving Legal Mechanisms for Ownership of Plant Genetic Resources,
28 Tulsa L.J. 587, 590
(1993). Commissioner of Patents v. President and Fellows of Harvard
College, (Can.), No. 28155, 12/5/02. http://www.percyschmeiser.com (last
visited March 14, 2003).
Rice was engineered
to include genetic material from daffodils causing vitamin A production. The resulting varieties have been as heavily
praised by the biotechnology industry, see http://www.isaaa.org/kc/,
GM Crops—rice– golden rice (last visited March 14, 2003), as they have
been criticized by the anti-genetic engineering movement, see http://www.grain.org/publications/delusion-en.cfm (last
visited March 14, 2003).
BIODIVERSITY
Africa's Fighting Chance. -The economic potential for Africa
John
Kilama. African
Innovators Need Strong IP Protection. Columbia Missouri Tribune).
John
Kilama. Plant Biotechnology Research and Development in Africa: Challenges and
Opportunities. June 12, 2003 WRITTEN TESTIMONY OF DR. ... [PDF] WRITTEN
TESTIMONY OF
John
Kilama. Collaboration with industry on traditional medicines. Global
Charles V. Barber, Lyle Glowka & Antonio G. M. La Vina, Developing
and Implementing National Measures for Genetic Resources Access
Regulation and Benefit Sharing, in Biodiversity
and Traditional Knowledge 363, 371-74 (Sarah A. Laird ed.,
2002). Sarah A. Laird & Kerry ten Kate, Biodiversity Prospecting: The Commercial
Use of Genetic Resources and Best Practice in Benefit Sharing,
in Biodiversity and Traditional
Knowledge 241, 243 (Sarah A. Laird ed., 2002). Sarah A. Laird & Kerry ten Kate, Biodiversity Prospecting: The Commercial
Use of Genetic Resources and Best Practice in Benefit Sharing,
in Biodiversity and Traditional
Knowledge 241, 241-42 (Sarah A. Laird ed., 2002). Michael A. Gollin, New Rules for Natural Products Research,
17 Nature Biotechnology 921 (1999). http://www.venable.com/publication.cfm?publication_type_ID=2&publication_ID=892
ENVIRONMENT
IPCC Special Report on Methodological and Technological Issues in Technology Transfer (available at http://www.ipcc.ch/activity/srtt-out.htm) (last visited March 6, 2003).
General Agreement
on Tariffs and Trade’s (GATT) Agreement on Trade-Related Aspects of
Intellectual Property Rights (TRIPS) Annex 1C to the General Agreement on
Tariffs and Trade, Uruguay Round, World Trade Organization, done at
Marrakesh, Apr. 15, 1994, 33 I.L.M. 1981 (1994), reprinted in World
Trade Organization, The Results of the Uruguay Round of Multilateral
Trade Negotiations 365 (1995) [hereinafter, -TRIPS”]. 31
I.L.M. 818 (opened for signature, June 5, 1992, entered into force
Dec. 29, 1993) [hereinafter, -CBD”]. International
Convention for the Protection of New Varieties of Plants (as revised at Geneva
on Mar. 19, 1991) (UPOV Publication No. 221(E)) [hereinafter, -UPOV”]. Michael A. Gollin, New Rules for Natural Products Research,
17 Nature Biotechnology 921
(1999) (discussing how recent changes to the legal environment have
profoundly affected the legalities associated with the collection of
biological samples). Intergovernmental Committee on Intellectual
Property and Genetic Resources, Traditional Knowledge and Folklore, Third Session, Geneva, June 13 to 21, 2002, WIPO Doc.
WIPO/GRTKF/IC/3/1-14 (available at http://www.wipo.int/globalissues/igc/documents/index.html#4)
(last visited March 6, 2003) [hereinafter, -WIPO IG-IPGRTKF”].
HEALTH CARE
In 2000, it was estimated that since the AIDS epidemic began, over 15
million Africans have died from AIDS and almost 25 million Sub-Saharan
Africans are infected with HIV/AIDS. World
Bank Press Release, -World
Bank Steps Up Fight Against AIDS in Africa,” dated Sept. 14, 2000. World Health Organization Essential Drugs and Medicines Policy (noting
that 50 percent of the population in developing countries lack access
to essential drugs and that 50-90 percent of drugs in developing countries
are paid for out-of-pocket, which places the heaviest burden on the
poor) (available at www.who.int/medicines). Michael A.
Gollin , Keep Drugs Coming, Legal Times. November 5, 2001 http://www.venable.com/docs/publication/936.pdf Michael A. Gollin, -Sustainable
Innovation for Public Health,” FDLI Update Magazine, January
2002 (available at http://www.venable.com/publication.cfm?publication_type_ID=2&publication_ID=816).
Carlos M. Correa, Intellectual
Property Rights, the WTO and Developing Countries: The TRIPS Agreement
and Policy Options (Zed
Books 2000), pp. 42-44.
For an overview and access to the relevant legal documents involved in
the debate over TRIPS and the provision of pharmaceuticals to developing
countries, including the latest materials relating to the Doha Declaration
see the website for the World Trade Organization ( -WTO”) (available
at http://www.wto.org/english/tratop_e/trips_e/pharmpatent_e.htm)
(last visited March 6, 2003). Office of the United States Trade Representative, U.S. Announces Interim Plan to
Help Poor Countries fight HIV/AIDS and other Health Crises in Absence
of WTO Consensus, dated Dec. 20, 2002 (available at http://www.ustr.gov/releases/2002/12/02-119.htm)
(last visited March 5, 2003).
The Global Forum for Health Research, Press Release 10/90 Report on Health
Research 2000: Narrowing
the 10/90 Gap in Health Research, dated May 2, 2000 ( -Less
than 10% of the estimated US$56 billion spent annually on health
research by the public and private sectors is devoted to diseases
or conditions that account for 90% of the global burden of disease.”)
(available at http://www.globalforumhealth.org/non_compliant_pages/report00/presserelease.htm)
(last visited March 5, 2003); see
also Initiative on Public-Private Partnerships for Health Mission
Statement (available at http://www.ippph.org/presentation/affich_mission.cfm?chap=4&sous_chap=0)
(last visited March 5, 2003). Michael A. Gollin, Sustainable
Innovation for Public Health, FDLI Update Magazine January/February
2002 (available at http://www.venable.com/publication.cfm?publication_type_ID=2&publication_ID=816).
INTELLECTUAL
PROPERTY
Michael A.
Gollin . Seven Changes Enacted In The Intellectual Property and Communications
Omnibus Reform Act of 1999. December 1, 1999
Michael Gollin, Rosemary
E. Dailey and Ronald W. Taylor. Protecting Your Company's Intellectual Property
Michael A. Gollin. Growing
A Business With Intellectual Property Checklist: Intellectual Property
Triggers
Michelle Syverson, Afterword, GATT, the Environment, and the Third World,
23 Envtl. L. 715, 716-17
(1992) Kirsten Peterson, Recent Development, Recent Intellectual Trends
in Developing Countries, 33 Harv.
Int'l L.J. 277, 277-78 (1992).
Commission on Intellectual Property Rights Final Report (available
at http://www.iprcommission.org/graphic/documents/final_report.htm)
(last visited March 14, 2003).
Edgar J. Asbey & Jill D. Kempenaar, Biodiversity Prospecting: Fulfilling the Mandate of the Biodiversity
Convention, 28 Vand.
J. Transnat’l L. 703, 707 (1995).
Justin Gillis, “To Feed Hungry Africans, Firms Plant Seeds
of Science,” Washington Post (March 11, 2003); p. A01.
INTERNET ACCESS
http://www.digitalopportunity.org/features/success_stories/.
International Treaty
on Cyber Crime, http://www.tilj.com/content/litigationarticle10110001.htm.
PATENT
Gollin, Michael A. and Haddaway, Keith G. Ph.D. "The American Inventors Protection Act Accelerates Patent Prosecution" . http://www.venable.com/docs/publication/937.pdf
Gollin,
Michael A. Requirements for U.S. Patents. January 1, 1996 http://www.venable.com/publication.cfm?publication_type_ID=2&publication_ID=899
Gollin,
Michael A. Invention Disclosure Worksheet A questionnaire intended to help
you organize information for preparing a patent application. January 1, 1996
TECHNOLOGY TRANSFER
IPCC Special Report on Methodological and Technological Issues in Technology Transfer (available at http://www.ipcc.ch/activity/srtt-out.htm) (last visited March 6, 2003).
TRADITIONAL KNOWLEDGE
AAAS – Handbook on Traditional
Knowledge. http://shr.aaas.org/tek/handbook Collaboration with industry on traditional medicines. John Kilama, Global Biodiversity Institute, USA . http://www.globalforumhealth.org/Non_compliant_pages/forum4/pppkilama.htm |
|
 |
ENGLISH ARABIC ESPAÑOL PORTUGUÊS CHINESE November 18, 2008 |
||||
 |
|||||